Catalent
CTLT
#1770
Rank
S$14.77 B
Marketcap
S$81.38
Share price
0.00%
Change (1 day)
9.66%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): S-$8.53

According to Catalent's latest financial reports the company's current EPS (TTM) is S-$8.11. In 2023 the company made an earnings per share (EPS) of S-$8.72 a decrease over its 2022 EPS that were of S$2.91.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)S-$8.53-2.16%
2023S-$8.72-399.56%
2022S$2.91-30.58%
2021S$4.1979.67%
2020S$2.33114.12%
2019S$1.09-15%
2018S$1.2875.44%
2017S$0.73-22.97%
2016S$0.95-59.56%
2015S$2.35282.05%
2014S$0.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
S-$0.42-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
S-$7.64-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
S-$0.96-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
S-$1.90-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA